D-4F decreases brain arteriole inflammation and improves cognitive performance in LDL receptor-null mice on a Western diet

J Lipid Res. 2006 Oct;47(10):2148-60. doi: 10.1194/jlr.M600214-JLR200. Epub 2006 Jul 11.

Abstract

LDL receptor-null mice on a Western diet (WD) have inflammation in large arteries and endothelial dysfunction in small arteries, which are improved with the apolipoprotein A-I mimetic D-4F. The role of hyperlipidemia in causing inflammation of very small vessels such as brain arterioles has not previously been studied. A WD caused a marked increase in the percent of brain arterioles with associated macrophages (microglia) (P < 0.01), which was reduced by oral D-4F but not by scrambled D-4F (ScD-4F; P < 0.01). D-4F (but not ScD-4F) reduced the percent of brain arterioles associated with CCL3/macrophage inflammatory protein-1alpha (P < 0.01) and CCL2/monocyte chemoattractant protein-1 (P < 0.001). A WD increased (P < 0.001) brain arteriole wall thickness and smooth muscle alpha-actin, which was reduced by D-4F but not by ScD-4F (P < 0.0001). There was no difference in plasma lipid levels, blood pressure, or arteriole lumen diameter with D-4F treatment. Cognitive performance in the T-maze continuous alternation task and in the Morris Water Maze was impaired by a WD and was significantly improved with D-4F but not ScD-4F (P < 0.05). We conclude that a WD induces brain arteriole inflammation and cognitive impairment that is ameliorated by oral D-4F without altering plasma lipids, blood pressure, or arteriole lumen size.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actins
  • Animals
  • Apolipoprotein A-I / pharmacology*
  • Arterioles / drug effects*
  • Arterioles / pathology*
  • Brain / blood supply*
  • Brain / drug effects*
  • Brain / pathology
  • Chemokine CCL2 / genetics
  • Chemokine CCL3
  • Chemokine CCL4
  • Cognition / drug effects
  • Diet
  • Female
  • Gene Expression Regulation
  • Hyperlipidemias / drug therapy
  • Inflammation / drug therapy
  • Macrophage Inflammatory Proteins / genetics
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Nootropic Agents / pharmacology*
  • Receptors, LDL / deficiency*
  • Receptors, LDL / genetics

Substances

  • Actins
  • Apolipoprotein A-I
  • Chemokine CCL2
  • Chemokine CCL3
  • Chemokine CCL4
  • D-4F peptide
  • Macrophage Inflammatory Proteins
  • Nootropic Agents
  • Receptors, LDL